Google DeepMind and Isomorphic Labs launch a bioresilience program to leverage AI models for pathogen surveillance, vaccine design, and outbreak responses
Google DeepMind and Isomorphic Labs launch a bioresilience program to leverage AI models for pathogen surveillance, vaccine design, and outbreak responses
Google DeepMind on Thursday unveiled a new bioresilience program designed to help governments and researchers prevent, detect and respond to biological threats.
Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025
Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …
Isomorphic Labs, an AI-powered drug discovery spinoff from Google DeepMind, raised $2.1B led by Thrive, after raising $600M in its first round in March 2025
Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion …
Sources: Isomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced talks to raise $2B+ led by Thrive Capital
Isomorphic Labs, an AI-powered drug discovery company spun out of Alphabet Inc.'s Google DeepMind, is in advanced discussions to raise …
Sources: Isomorphic Labs, an AI-powered drug discovery company spun out of Google DeepMind, is in advanced talks to raise $2B+ led by Thrive Capital
Isomorphic Labs, an AI-powered drug discovery company spun out of Alphabet Inc.'s Google DeepMind, is in advanced discussions to raise …
Isomorphic Labs, a Google DeepMind spinoff, unveils IsoDDE, a system that it says surpasses AlphaFold 3 in biomolecular structure prediction and drug discovery
Today, we are excited to share an update on our progress towards a new frontier of drug design. We have unlocked a new paradigm …
A look at Isomorphic Labs, a life sciences startup spun out of Google DeepMind, both led by Demis Hassabis, aiming to “solve all disease” via AI drug discovery
They recently raised $600 million in external funding. Today, they made AlphaFold3 available to the scientific community. www.cnbc.com/2025/04/09/i... LinkedIn: Hayden Field : On a rare sunny day in ...
Isomorphic Labs, a DeepMind spinoff focusing on drug discovery, raised $600M led by Thrive to research treatments, including for cancer and immune disorders
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.
Q&A with Google DeepMind's Demis Hassabis on his Nobel Prize being “a watershed moment for AI”, biology, AlphaFold 3, Isomorphic Labs, drug programs, and more
Madhumita Murgia / Financial Times :